financetom
Business
financetom
/
Business
/
Apple's iPhone 17 Likely to Have 'Marginal Changes,' UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple's iPhone 17 Likely to Have 'Marginal Changes,' UBS Says
Sep 8, 2025 8:33 AM

11:05 AM EDT, 09/08/2025 (MT Newswires) -- Apple ( AAPL ) is expected to launch an iPhone 17 with "marginal changes" at its "Awe Dropping" event on Tuesday, UBS Securities said in a note emailed Monday.

The brokerage said it expects the company to unveil the iPhone Air to replace the Plus model in the lineup to launch a "relatively new form factor" for the phone.

A thinner device, however, would "have a muted impact on consumer purchasing decisions and thus, limited upside" to UBS' iPhone estimates for the September and December quarters, the brokerage said.

UBS said other hardware announcements at the event "are likely to be more evolutionary," such as a new iPad Pro with the M5 chip.

UBS maintained Apple's ( AAPL ) neutral rating and $220 price target.

Price: 238.99, Change: -0.70, Percent Change: -0.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Repsol, NEO Energy Merge In North Sea Deal, Targeting $1 Billion In Synergies
Repsol, NEO Energy Merge In North Sea Deal, Targeting $1 Billion In Synergies
Mar 27, 2025
Repsol S.A. ( REPYF )‘s (OTC:REPYY) Repsol Resources UK disclosed a strategic merger deal with NEO Energy (NEO) on Thursday, creating a major independent producer in the North Sea. The newly merged entity will be rebranded as NEO NEXT Energy Limited. As per the deal, the merged entity will be co-owned by NEO (55%) and Repsol UK (45%), with Repsol...
Merck plans to  launch US subcutaneous version of Keytruda on October 1
Merck plans to  launch US subcutaneous version of Keytruda on October 1
Mar 27, 2025
NEW YORK, March 27 (Reuters) - Merck & Co ( MRK ) said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the U.S. on October 1, and expects to hit peak adoption rates of the new version within two years. The subcutaneous version of the drug is not yet approved...
Ferrari raises some prices in response to U.S auto tariffs
Ferrari raises some prices in response to U.S auto tariffs
Mar 27, 2025
ROME, March 27 (Reuters) - Ferrari plans to increase the prices of some of its cars sold in the United States in response to new tariffs, the luxury carmaker said on Thursday, adding it would stick largely to its financial targets for this year. The U.S. on Wednesday announced a 25% tariff on auto imports shaking the whole sector worldwide,...
EV Maker Mullen Automotive To Further Cut Costs And Slash Workforce: Details
EV Maker Mullen Automotive To Further Cut Costs And Slash Workforce: Details
Mar 27, 2025
Shares of electric vehicle maker Mullen Automotive Inc. ( MULN ) are trading lower on Thursday. Automakers’ stocks declined after the White House announced President Donald Trump would introduce new tariffs on auto imports. In another development, Mullen announced cost-cutting measures on Thursday. As part of its ongoing efforts to optimize operations, the company has implemented additional cost-cutting measures, including workforce...
Copyright 2023-2026 - www.financetom.com All Rights Reserved